PTSD Trial, Recruiting NCT04922762 Sponsor: Virginia Commonwealth University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT04922762
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who appear to be generally healthy and do not have obvious heart, lung, or metabolic conditions (such as diabetes)
  • People applying for the PTSD group must score 33 or higher on a standard PTSD symptom checklist called the PCL-5
  • People applying for the Generalized Anxiety Disorder (GAD) group must score 10 or higher on a standard anxiety questionnaire called the GAD-7, and score below 33 on the PCL-5 checklist
  • People applying for the Healthy Control group must score 10 or below on the GAD-7 anxiety questionnaire and below 33 on the PCL-5 checklist

Who may not be able to join:

  • People who are currently taking medications that could affect how the heart or blood vessels work
  • People who currently smoke or have recently quit smoking
  • People who use illicit drugs or drink alcohol excessively
  • People who are pregnant
  • People who are on a significant calorie-restricted diet or who have known vitamin or mineral deficiencies
  • People with limited English language ability

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ryan Garten, PhD, Virginia Commonwealth University

Phone: (804) 828-1948

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 December 2021
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Arm Vascular Function at Rest (Flow Mediated Dilation Test); Leg Vascular Function (Passive Leg Movement Test); Arm Vascular Function in Response to Exercise (Handgrip Exercise Test)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov